• About
  • Masthead
  • License Content
  • Advertise
  • Submit Press Release
  • RSS/Email List
  • 2MM Podcast
  • Write for us
  • Contact Us
2 Minute Medicine
No Result
View All Result

No products in the cart.

SUBSCRIBE
  • About
  • Specialties
    • All Specialties, All Recent Reports
    • Cardiology
    • Chronic Disease
    • Dermatology
    • Emergency
    • Endocrinology
    • Gastroenterology
    • Imaging and Intervention
    • Infectious Disease
    • Nephrology
    • Neurology
    • Obstetrics
    • Oncology
    • Ophthalmology
    • Pediatrics
    • Pharma
    • Preclinical
    • Psychiatry
    • Public Health
    • Pulmonology
    • Rheumatology
    • Surgery
  • Tools+
    • EvidencePulse™
    • HypeCheck™
    • NPI Registry Lookup
    • RVU Search
  • Pharma
  • AI Roundup
  • The Scan+
  • Classics™+
    • 2MM+ Online Access
    • Paperback and Ebook
  • Rewinds
  • Partners
    • License Content
    • Submit Press Release
    • Advertise with Us
  • Account
    • Subscribe
    • My account
    • Cart
    • Sign-in
2 Minute Medicine
  • About
  • Specialties
    • All Specialties, All Recent Reports
    • Cardiology
    • Chronic Disease
    • Dermatology
    • Emergency
    • Endocrinology
    • Gastroenterology
    • Imaging and Intervention
    • Infectious Disease
    • Nephrology
    • Neurology
    • Obstetrics
    • Oncology
    • Ophthalmology
    • Pediatrics
    • Pharma
    • Preclinical
    • Psychiatry
    • Public Health
    • Pulmonology
    • Rheumatology
    • Surgery
  • Tools+
    • EvidencePulse™
    • HypeCheck™
    • NPI Registry Lookup
    • RVU Search
  • Pharma
  • AI Roundup
  • The Scan+
  • Classics™+
    • 2MM+ Online Access
    • Paperback and Ebook
  • Rewinds
  • Partners
    • License Content
    • Submit Press Release
    • Advertise with Us
  • Account
    • Subscribe
    • My account
    • Cart
    • Sign-in
SUBSCRIBE
2 Minute Medicine
Subscribe
EvidencePulse™ by 2 Minute Medicine 2026 evidence scan 3 reports You asked top stroke trials 2026 Synthesizing medical evidence... Top 2026 stroke trial results: OCEANIC — ischemic stroke: 6.2% vs 8.4% OPTION* — mRS 0–1: 43.6% vs 34.2% ORIENTAL* — mRS 0–2: 58.6% vs 46.6% *Higher sICH in intervention arms Participants randomizedN OCEANIC 12,327 OPTION 570 ORIENTAL 564 Ask about guidelines or landmark trials... ↑ Try EvidencePulse™ Ask the evidence.
Get the signal.
Try it now → Physician-trained medical AI by 2 Minute Medicine
Home All Specialties Chronic Disease

Diffusion-weighted MRI sensitive for metastasis in pelvic lymph nodes

byXiaofan PanandAaron Maxwell, MD
June 11, 2014
in Chronic Disease, Imaging and Intervention, Oncology
Reading Time: 2 mins read
MRI helps predict risk of local recurrence in upper rectal cancers
Share on FacebookShare on Twitter

1.Diffusion-weighted magnetic resonance imaging (DWMRI)  was shown to be both sensitive and specific for identification of pelvic lymph node metastases among patients with prostate or bladder cancer. 

2. The inclusion of several additional imaging criteria in conjunction with DWMRI reduced the number of diagnostic errors and was associated with superior sensitivity relative to DWMRI alone. 

Evidence Rating Level: 2 (Good) 

Study Rundown: The presence of metastasis to local lymph nodes alters cancer staging and may influence treatment decisions. The current protocol for the evaluation of lymph node metastasis involves preoperative imaging with either computed tomography (CT) or magnetic resonance imaging (MRI), which detect lymph nodes primarily based on size. These techniques are currently limited by their insensitivity to smaller lymph nodes containing metastases, and may yield falsely positive results in hypertrophic lymph nodes. DWMRI represents a promising alternative detection method, as it is very sensitive to the subtle changes caused by invasion from cancer cells.

In the present study, the performance of DWMRI in the identification of lymph node metastasis was evaluated among patients with prostate or bladder cancer. Using histopathologic evaluation as the reference standard, DWMRI showed a high sensitivity and specificity. The study’s primary limitation was its single-institution design, and further work is necessary to replicate these findings at other medical centers.

Click to read the study in Radiology

RELATED REPORTS

2 Minute Medicine Rewind August 3rd, 2026

Enzalutamide (Xtandi) and abiraterone (Zytiga) may have similar effectiveness in metastatic castration-sensitive prostate cancer

Stockholm3 outperforms PSA for detecting significant prostate cancer 

Relevant Reading: Noninvasive detection of clinically occult lymph-node metastases in prostate cancer

In-Depth [nonrandomized clinical trial]: The study enrolled 120 consecutive patients at a single institution with bladder or prostate cancer who had been previously staged as having no metastases (N0) by conventional preoperative cross-sectional imaging (CT and/or MRI). All enrolled patients underwent DWMRI at 3.0 Tesla to evaluate for previously-unidentified pelvic lymph node metastases. Images were reviewed both pre- and postoperatively, as well as in conjunction with standard MRI for the evaluation of several prespecified imaging criteria (e.g. lymph node shape). All patients subsequently underwent tumor resection with extended pelvic lymph node dissection. Imaging results were compared to histopathologic examination of removed lymph nodes for the diagnosis of metastasis. In total, 33 patients (27.5%) had histologically-confirmed metastasis in 88 lymph nodes. Using DWMRI,  metastasis was correctly identified in 24/33 patients, yielding an overall sensitivity, specificity, and diagnostic accuracy of 72.7%, 86.2%, and 82.5%, respectively. Most false negative examinations were in very small nodes, less than 5 millimeters in diameter. Following incorporation of the additional MRI-based imaging criteria into lymph node assessment, sensitivity increased to 94.5%.

Image: PD

©2012-2014 2minutemedicine.com. All rights reserved. No works may be reproduced without expressed written consent from 2minutemedicine.com. Disclaimer: We present factual information directly from peer reviewed medical journals. No post should be construed as medical advice and is not intended as such by the authors, editors, staff or by 2minutemedicine.com. PLEASE SEE A HEALTHCARE PROVIDER IN YOUR AREA IF YOU SEEK MEDICAL ADVICE OF ANY SORT.

Tags: bladder cancermetastasismriprostate cancer
Previous Post

Addition of insulin to metformin in Type 2 Diabetes may increase risk of mortality

Next Post

Hydrolyzed formula in susceptible infants does not reduce Diabetes-linked autoantibodies

RelatedReports

Elagolix with add-back hormone therapy effective in reducing fibroid-associated menstrual bleeding
Weekly Rewinds

2 Minute Medicine Rewind August 3rd, 2026

August 3, 2026
Radiation plus hormone therapy may improve prostate cancer survival
Chronic Disease

Enzalutamide (Xtandi) and abiraterone (Zytiga) may have similar effectiveness in metastatic castration-sensitive prostate cancer

July 22, 2026
Patient-reported outcomes differ significantly based on treatment in prostate cancer: The ProtecT trial
Oncology

Stockholm3 outperforms PSA for detecting significant prostate cancer 

June 22, 2026
Radiation plus hormone therapy may improve prostate cancer survival
Oncology

Pfizer’s Talzenna combo significantly delays prostate cancer progression

April 9, 2026
Next Post
Weight loss may decrease urinary incontinence in male diabetics [Look AHEAD Study]

Hydrolyzed formula in susceptible infants does not reduce Diabetes-linked autoantibodies

Levodopa for Parkinson’s disease more effective than newer generation therapies

Levodopa for Parkinson’s disease more effective than newer generation therapies

ADHD stimulant treatment associated with changes in BMI trajectory

Combination CPAP, weight loss for obstructive sleep apnea offer no added benefit

EvidencePulse™ by 2 Minute Medicine 2026 evidence scan 3 reports You asked top stroke trials 2026 Synthesizing medical evidence... Top 2026 stroke trial results: OCEANIC — ischemic stroke: 6.2% vs 8.4% OPTION* — mRS 0–1: 43.6% vs 34.2% ORIENTAL* — mRS 0–2: 58.6% vs 46.6% *Higher sICH in intervention arms Participants randomizedN OCEANIC 12,327 OPTION 570 ORIENTAL 564 Ask about guidelines or landmark trials... ↑ Try EvidencePulse™ Ask the evidence.
Get the signal.
Try it now → Physician-trained medical AI by 2 Minute Medicine

2MM+ All Access

Full details →
$4.99 /month

5-day free trial · cancel anytime

  • ✓100+ physician-written reports
  • ✓EvidencePulse™ + HypeCheck™
  • ✓Ad-free reading + newsletters
Start 5-day free trial

Then $4.99/month. Manage renewal in your account.

2 Minute Medicine® is an award winning, physician-run, expert medical media company. Our content is curated, written and edited by practicing health professionals who have clinical and scientific expertise in their field of reporting. Our editorial management team is comprised of highly-trained MD physicians. Join numerous brands, companies, and hospitals who trust our licensed content.

Recent Reports

  • The use of neoadjuvant chemotherapy in patients with advanced epithelial ovarian cancer may reduce mortality
  • Alcohol use declines but remains above pre-pandemic levels
  • High maternal egg-peanut intake not associated with reduced infant allergy
License Content
Terms of Use | Disclaimer
Cookie Policy
Cleantalk Pixel
2MM+ All Access Full details →

The medical literature, distilled daily.

Monthly plan selected: $4.99 /month.

$4.99/month

5-day free trial · cancel anytime

Start 5-day free trial

Then $4.99/month. Manage renewal in your account.

Yearly plan selected: $49.90 /year.

$49.90/year

2 months free · only $4.16/month

Start 5-day free trial

Then $49.90/year. Manage renewal in your account.

Membership benefits

  • ✓100+ physician-written reports
  • ✓AI EvidencePulse™ + HypeCheck™
  • ✓Ad-free reading + newsletters

Already a member? Sign in

  • About
  • Specialties
    • All Specialties, All Recent Reports
    • Cardiology
    • Chronic Disease
    • Dermatology
    • Emergency
    • Endocrinology
    • Gastroenterology
    • Imaging and Intervention
    • Infectious Disease
    • Nephrology
    • Neurology
    • Obstetrics
    • Oncology
    • Ophthalmology
    • Pediatrics
    • Pharma
    • Preclinical
    • Psychiatry
    • Public Health
    • Pulmonology
    • Rheumatology
    • Surgery
  • Tools
    • EvidencePulse™
    • HypeCheck™
    • NPI Registry Lookup
    • RVU Search
  • Pharma
  • AI Roundup
  • The Scan
  • Classics™
    • 2MM+ Online Access
    • Paperback and Ebook
  • Rewinds
  • Partners
    • License Content
    • Submit Press Release
    • Advertise with Us
  • Account
    • Subscribe
    • My account
    • Cart
    • Sign-in
No Result
View All Result

© 2026 2 Minute Medicine, Inc. - Physician-written medical news.